Ageing, lifestyle changes, limited access to healthcare and socio-economic challenges have contributed heavily to the rising mortality rate among Kenya's elderly population, raising concerns about the ...

Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company with a market capitalization of $156.6 million, is at a pivotal juncture in its development of programmed cellular ...

The findings suggest that reconsideration of current clinical guidelines, which support MRI only for symptomatic brain ...

RFK Jr.'s confirmation hearings continue today as he appears before a second Senate committee. Follow STAT's live updates.

Dwyane Wade, an NBA legend, Chicago native and former Chicago Bulls guard, revealed on Thursday that he was diagnosed with ...

MILWAUKEE - Dwyane Wade, NBA legend and former Marquette Golden Eagles standout, revealed on Thursday that he was diagnosed ...

Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of ...

A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.

Atezolizumab (Tecentriq) plus chemotherapy after surgery did not improve survival in high-risk triple-negative breast cancer, according to a global phase 3 trial.

People with first-degree relatives who were repeatedly diagnosed with colorectal polyps appeared at increased risk for ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, today we look at ...

Shares in clinical-stage biotechnology company Cargo Therapeutics (CRGX) have plunged after it scrapped trials of a cancer ...